Efficacy and Safety of Sofosbuvir Plus Ribavirin in Chronic Genotype 1, 2 and 3 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-infected Adults
Clinical trial NCT01667731 · COMPLETED
Trial details
- NCT number
- NCT01667731
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-01
- Primary completion
- 2013-11-01
- Enrollment
- 224
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.